S 3228 United States Senate · 119th Congress

SIMSA Act of 2025

The SIMSA Act of 2025 creates a new Schedule A for controlled substances under federal drug law. It defines Schedule A substances as those imported into the U.S. with chemical structures substantially similar to existing Schedule I-V substances and having similar effects on the central nervous system. The bill establishes procedures for the Attorney General to temporarily schedule substances for up to 5 years (with possible 180-day extensions), requiring consultation with the Secretary of Health and Human Services before permanent scheduling. It increases penalties for violations involving Schedule A substances, including prison terms up to 30 years for repeat offenses and higher fines, and requires specific labeling with IUPAC nomenclature for these substances.
Bill status in committee 1 of 4 stages cleared
Introduction
Nov 2025
Committee Review
Floor Vote
President
Introduced Nov 20, 2025 Last action Nov 20, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Nov 20, 2025
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Nov 20, 2025
Introduced
Introduced in Senate
upper
1 primary · 4 co-sponsors

Sponsors